Study of Efficacy of BZ019 in Large B-cell Lymphoma

NCT05472610 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma

Interventions

BIOLOGICAL: BZ019

Sponsor

Shanghai Mengchao Cancer Hospital

Collaborators

[object Object]